Abstract:Background: Parkinson’s disease (PD) is a severe neurodegenerative disease associated with loss of dopaminergic neurons. Derivation of dopaminergic neurons from human embryonic stem cells (hESCs) could provide new therapeutic options for PD therapy. Dopaminergic neurons are derived from SOX floor plate (FP) cells during embryonic development in many species and in human cell culture in vitro. Early treatment with sonic hedgehog (Shh) has been reported to efficiently convert hESCs into FP lineages. Methods: In this study, we attempted to utilize a Shh-free approach in deriving SOX1 FP cells from hESCs in vitro. Neuroectoderm conversion from hESCs was achieved with dual inhibition of the BMP4 (LDN193189) and TGF-β signaling pathways (SB431542) for 24 h under defined culture conditions. Results: Following a further 5 days of treatment with LDN193189 or LDN193189 + SB431542, SOX1 FP cells constituted 70–80 % of the entire cell population. Upon treatment with Shh and FGF8, the SOX1 FP cells were efficiently converted to functional Nurr1 and TH dopaminergic cells (patterning), which constituted more than 98 % of the entire cell population. However, when the same growth factors were applied to SOX1 cells, only less than 4 % of the cells became Nurr1, indicating that patterning was effective only if SOX1 expression was down-regulated. After transplanting the Nurr1 and TH cells into a hemiparkinsonian rat model, significant improvements were observed in amphetamine induced ipslateral rotations, apomorphine induced contra-lateral rotations and Rota rod motor tests over a duration of 8 weeks. Conclusions: Our findings thus provide a convenient approach to FP development and functional dopaminergic neuron derivation.

Cell Cycle and P53 Gate the Direct Conversion of Human Fibroblasts to Dopaminergic Neurons

Title Efficient derivation of dopaminergic neurons from SOX 1 (-) floorplate cells under defined culture conditions

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Chemical Conversion of Mouse Fibroblasts into Functional Dopaminergic Neurons

Conversion of Fibroblasts to Neural Cells by P53 Depletion

Direct Reprogramming of Human Fibroblasts into Dopaminergic Neuron-Like Cells

RESULTS Knockout of p 53 Converts Fibroblasts into Neurons , Astrocytes , and Oligodendrocytes

Selective Generation of Dopaminergic Precursors from Mouse Fibroblasts by Direct Lineage Conversion

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Attenuation of PRRX2 and HEY2 Enables Efficient Conversion of Adult Human Skin Fibroblasts to Neurons.

Generation of naivetropic induced pluripotent stem cells from Parkinson's disease patients for high efficiency genetic manipulation

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Current Approaches and Molecular Mechanisms for Directly Reprogramming Fibroblasts Into Neurons and Dopamine Neurons

Reprogramming Fibroblasts Toward Cardiomyocytes, Neural Stem Cells and Hepatocytes by Cell Activation and Signaling-Directed Lineage Conversion

Myt1l induced direct reprogramming of pericytes into cholinergic neurons.

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.